Changes in hepatitis B vaccine perception in response to the COVID-19 pandemic: Development of the Shift in vaccine confidence (SVC) survey tool.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
16 01 2023
Historique:
received: 04 01 2022
revised: 18 11 2022
accepted: 13 12 2022
pubmed: 23 12 2022
medline: 4 1 2023
entrez: 22 12 2022
Statut: ppublish

Résumé

The COVID-19 pandemic has disrupted access to, adherence to, and perceptions of routine vaccinations. We developed the Shift in Vaccine Confidence (SVC) survey tool to assess the impact of the pandemic on routine vaccinations, with a focus on the HBV vaccine, in Kinshasa, Democratic Republic of Congo (DRC). This study describes the content validation steps we conducted to ensure the survey tool is meaningful to measure changes in vaccine confidence to regular immunization (HBV vaccine) due to the pandemic. Three rounds of stakeholder feedback from a DRC-based study team, content and measurement experts, and study participants allowed us to produce a measure with improved readability and clarity.

Identifiants

pubmed: 36549941
pii: S0264-410X(22)01542-0
doi: 10.1016/j.vaccine.2022.12.028
pmc: PMC9755009
pii:
doi:

Substances chimiques

Hepatitis B Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

623-629

Subventions

Organisme : NIAID NIH HHS
ID : K08 AI148607
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [Alix Boisson reports a relationship with Drusilla L. Scott Summer Research Fellowship that includes: funding grants. Camille Johnson reports a relationship with National Institutes of Health that includes: funding grants. Angela Stover reports a relationship with Patient-Centered Outcomes Research Institute that includes: funding grants. Angela Stover reports a relationship with National Institutes of Health that includes: funding grants. Angela Stover reports a relationship with Agency for Healthcare Research and Quality that includes: funding grants. Angela Stover reports a relationship with Bladder Cancer Advocacy Network that includes: funding grants. Angela Stover reports a relationship with Sivan Innovations that includes: funding grants. Angela Stover reports a relationship with UroGen Pharma that includes: funding grants. Angela Stover reports a relationship with Association of Community Cancer Centers that includes: speaking and lecture fees. Angela Stover reports a relationship with Pfizer Inc that includes: speaking and lecture fees. Angela Stover reports a relationship with Genentech that includes: speaking and lecture fees. Angela Stover reports a relationship with Purchaser Business Group on Health that includes: funding grants. Angela Stover reports a relationship with Henry Ford Cancer Institute - Detroit that includes: speaking and lecture fees. Peyton Thompson reports a relationship with Novavax Inc that includes: funding grants. Peyton Thompson reports a relationship with National Institutes of Health that includes: funding grants. Peyton Thompson reports a relationship with American Society of Tropical Medicine and Hygiene that includes: funding grants. Jonathan B. Parr reports a relationship with Gilead Sciences Inc that includes: funding grants. Peyton Thompson reports a relationship with Gilead Sciences Inc that includes: funding grants. Jonathan B. Parr reports a relationship with Abbott Diagnostics that includes: non-financial support. Marcel Yotebieng reports a relationship with Abbott Diagnostics that includes: non-financial support. Peyton Thompson reports a relationship with Abbott Diagnostics that includes: non-financial support. Jonathan B. Parr reports a relationship with Virology Education that includes: speaking and lecture fees].

Références

Lancet Microbe. 2021 Aug;2(8):e347-e348
pubmed: 34179857
Vaccine. 2019 Jan 7;37(2):325-332
pubmed: 30503657
PLoS One. 2018 Dec 7;13(12):e0208601
pubmed: 30532274
Acad Pediatr. 2016 Jan-Feb;16(1):42-9
pubmed: 26300368
JAMA Pediatr. 2013 Nov;167(11):1065-71
pubmed: 24061681
Vaccine. 2015 Aug 14;33(34):4165-75
pubmed: 25896384
Lancet. 2021 Aug 7;398(10299):522-534
pubmed: 34273292
Front Pediatr. 2020 Aug 06;8:517
pubmed: 32850565
Hum Vaccin Immunother. 2019;15(5):1191-1198
pubmed: 30779684
Vaccines (Basel). 2021 Feb 14;9(2):
pubmed: 33672938
Lancet. 2020 Sep 26;396(10255):898-908
pubmed: 32919524
Vaccine. 2018 Jun 18;36(26):3861-3867
pubmed: 29605516
Prev Med. 2018 Apr;109:1-7
pubmed: 29337069
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
Health Qual Life Outcomes. 2009 Jan 23;7:3
pubmed: 19166601

Auteurs

Alix Boisson (A)

Department of Health Policy and Management, Gillings School of Global Public Health, The University of North Carolina, Chapel Hill, NC, 27599, USA. Electronic address: aboisson@unc.edu.

Camille E Morgan (CE)

Department of Epidemiology, Gillings School of Global Public Health, The University of North Carolina, Chapel Hill, NC, 27599, USA. Electronic address: camille_morgan@med.unc.edu.

Angela Stover (A)

Department of Health Policy and Management, Gillings School of Global Public Health, The University of North Carolina, Chapel Hill, NC, 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599. Electronic address: stoveram@email.unc.edu.

Patrick Ngimbi (P)

Université Protestante du Congo, Kinshasa, Democratic Republic of the Congo. Electronic address: patrickngimbi1@gmail.com.

Nana Mbonze (N)

Université Protestante du Congo, Kinshasa, Democratic Republic of the Congo. Electronic address: mbonzenana@gmail.commbo.

Sarah Ntambua (S)

Université Protestante du Congo, Kinshasa, Democratic Republic of the Congo. Electronic address: sarahntambua2017@gmiail.com.

Jolie Matondo (J)

Université Protestante du Congo, Kinshasa, Democratic Republic of the Congo. Electronic address: joliematondo83@gmail.com.

Jonathan B Parr (JB)

Division of Infectious Diseases, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. Electronic address: jonathan_parr@med.unc.edu.

Marcel Yotebieng (M)

Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, 10461, USA. Electronic address: marcel.yotebieng@einsteinmed.org.

Kashamuka Mwandagalirwa (K)

Université Protestante du Congo, Kinshasa, Democratic Republic of the Congo. Electronic address: mkashamuka@yahoo.com.

Linda James (L)

Université Protestante du Congo, Kinshasa, Democratic Republic of the Congo. Electronic address: lindajames.la@gmail.com.

Samuel Mampunza (S)

Université Protestante du Congo, Kinshasa, Democratic Republic of the Congo. Electronic address: mampunza.samuel@upc.ac.cd.

Peyton Thompson (P)

Division of Infectious Diseases, Department of Pediatrics, University of North Carolina, Chapel Hill, NC 27599, USA. Electronic address: peyton_thompson@med.unc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH